Jeffrey Points Acquires 2,000 Shares of Shoulder Innovations (NYSE:SI) Stock

Shoulder Innovations, Inc. (NYSE:SI) CFO Jeffrey Points purchased 2,000 shares of the firm’s stock in a transaction that occurred on Friday, March 13th. The shares were acquired at an average cost of $15.00 per share, with a total value of $30,000.00. Following the completion of the purchase, the chief financial officer directly owned 70,785 shares in the company, valued at $1,061,775. The trade was a 2.91% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink.

Shoulder Innovations Stock Performance

Shares of Shoulder Innovations stock opened at $15.18 on Thursday. The company has a quick ratio of 9.55, a current ratio of 11.07 and a debt-to-equity ratio of 0.11. The stock’s fifty day moving average is $13.77 and its two-hundred day moving average is $13.86. Shoulder Innovations, Inc. has a 52 week low of $10.92 and a 52 week high of $17.94. The company has a market capitalization of $313.36 million and a PE ratio of -0.07.

Shoulder Innovations (NYSE:SI) last released its earnings results on Tuesday, March 10th. The company reported ($0.38) earnings per share for the quarter, topping the consensus estimate of ($0.42) by $0.04. The business had revenue of $14.42 million during the quarter, compared to the consensus estimate of $12.69 million. Shoulder Innovations had a negative return on equity of 37.68% and a negative net margin of 85.29%. As a group, analysts expect that Shoulder Innovations, Inc. will post -0.56 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Morgan Stanley lifted their price objective on shares of Shoulder Innovations from $18.00 to $23.00 and gave the company an “overweight” rating in a report on Tuesday, December 2nd. BTIG Research raised their target price on shares of Shoulder Innovations from $23.00 to $24.00 and gave the stock a “buy” rating in a research report on Wednesday, March 11th. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Shoulder Innovations in a research note on Friday, January 9th. Finally, Weiss Ratings reiterated a “sell (e)” rating on shares of Shoulder Innovations in a report on Monday, December 29th. Five investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $20.80.

Institutional Trading of Shoulder Innovations

Hedge funds have recently modified their holdings of the company. Sectoral Asset Management Inc. boosted its holdings in shares of Shoulder Innovations by 14.4% in the 4th quarter. Sectoral Asset Management Inc. now owns 492,435 shares of the company’s stock valued at $7,042,000 after buying an additional 62,153 shares in the last quarter. Deerfield Management Company L.P. bought a new position in shares of Shoulder Innovations during the 3rd quarter worth approximately $6,056,000. Alyeska Investment Group L.P. bought a new position in shares of Shoulder Innovations during the 3rd quarter worth approximately $5,667,000. TimesSquare Capital Management LLC purchased a new stake in Shoulder Innovations during the third quarter valued at approximately $4,799,000. Finally, Federated Hermes Inc. acquired a new stake in Shoulder Innovations in the third quarter valued at approximately $2,510,000.

About Shoulder Innovations

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.